Lindsay A. Rosenwald

2022

In 2022, Lindsay A. Rosenwald earned a total compensation of $1.3M as Chairman, President and Chief Executive Officer at Fortress Biotech.

Compensation breakdown

Salary$62,665
Stock Awards$1,053,576
Other$150,000
Total$1,266,242

Rosenwald received $1.1M in stock awards, accounting for 83% of the total pay in 2022.

Rosenwald also received $62.7K in salary and $150K in other compensation.

Rankings

In 2022, Lindsay A. Rosenwald's compensation ranked 2,569th out of 5,676 executives tracked by ExecPay. In other words, Rosenwald earned more than 54.7% of executives.

ClassificationRankingPercentile
All
2,569
out of 5,676
55th
Division
Manufacturing
1,420
out of 3,084
54th
Major group
Chemicals And Allied Products
645
out of 1,399
54th
Industry group
Drugs
599
out of 1,300
54th
Industry
Pharmaceutical Preparations
428
out of 942
55th
Source: SEC filing on April 5, 2024.

Rosenwald's colleagues

We found two more compensation records of executives who worked with Lindsay A. Rosenwald at Fortress Biotech in 2022.

2022

David Jin

Fortress Biotech

Chief Financial Officer

2022

Michael Weiss

Fortress Biotech

Chairman

News

You may also like